Research Article
First Report of the HEV Seroprevalence and the Risk Factor Assessment in the West Bank, Palestine, during the Period of 2015–2017
Figure 1
Spot map of the 16 HEV-IgG positive cases (red). The blue circles represent study participants from the 11 Palestinian districts. The numbers in the red circles represent the number of HEV-IgG positive samples in that geographical spot.